Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
42%
Parkinson
20%
Clinical Data
12%
GBA1
11%
Interpretable Machine Learning
11%
Xanthine
9%
Dopaminergic Pathway
9%
Long-read Sequencing
9%
Metabolic Function
9%
Relevant Changes
9%
Luxembourgish
9%
Levodopa-induced Dyskinesia
9%
Cardiovascular History
9%
Disease Duration
9%
Major Risk Factors
9%
Prognostic Analysis
9%
Risk Variant
9%
Variant Severity
9%
Cross-cohort
9%
Motor Fluctuations
9%
Authorship Criteria
9%
Metabolomics Data
9%
Outcome Prediction
9%
Gait Data
9%
Mild Cognitive Impairment
9%
Clinical Decision Support Tool
9%
Pandemic Control Measures
9%
Social Determinants of Mental Health
9%
Medicine and Dentistry
Parkinson's Disease
47%
Gut Microbiome
19%
Heart Arrest
19%
Metabolomics
19%
Diseases
14%
National Health Service
9%
Intensive Care Medicine
9%
Clinical Research
9%
Medical Research
9%
Mild Cognitive Impairment
9%
microRNA
9%
Progressive Supranuclear Palsy
9%
Observational Study
9%
Cardiovascular System
9%
Comorbidity
9%
Biological Marker
7%
Cardiovascular Disease
5%
Neuroscience
Parkinson's Disease
100%
Mild Cognitive Impairment
31%
L-DOPA
19%
Dyskinesia
19%
Comorbidity
14%
Progressive Supranuclear Palsy
9%
MicroRNA
9%
Memory Disorder
9%
Cognitive Disorders
9%